ALI revenues decline in Q3Purchasing delays related to the year 2000 problem weighed down financial results at ultrasound miniPACS firm ALI Technologies. During its fiscal third quarter (end-June), ALI posted revenues of $3.7 million (U.S.), an
Purchasing delays related to the year 2000 problem weighed down financial results at ultrasound miniPACS firm ALI Technologies. During its fiscal third quarter (end-June), ALI posted revenues of $3.7 million (U.S.), an increase of 7% over the same period in 1998, but a decrease of 22% from second-quarter 1999 (end-March). The company attributed the decrease to Y2K software conformance issues its clients are facing.
During the quarter, the company incurred a net loss of $178,302, and sustained a charge of $231,058 for restruct-uring costs related to its purchase of Olicon Imaging Systems (PNN 7/99). ALI reported that its integration of Olicons image management business is almost complete.
ALI also announced that two multimodality sites are in clinical operation under its introductory beta site pilot program (PNN 12/98), which will be completed in the fall. In addition, the Vancouver, BC-based company has purchase commitments for three additional multimodality systems from Pitt County Memorial Hospital in Greenville, NC, the University of California, Los Angeles Santa Monica Clinic in Santa Monica, CA, and the Texas Health System-Arlington Memorial South Medical Center in Dallas.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.